Comprehensive Cancer Care Services

Research | Current Clinical Trials

Research has led to progress against many types of cancer -

  • Better Treatments
  • a Lower Chance of Death from the Disease
  • and Improved Quality of Life.

Through research, knowledge about cancer keeps increasing. Scientists are learning more about what causes cancer and are finding new ways to prevent, detect, diagnose, and treat this disease.

Highlands Oncology Group, PA has been participating in clinical trials for over 15 years. The research department started with a small staff of one who performed all duties. Today, our current staff includes a Research Director, 2 Phase I Coordinators, 5 Phase II/III/IV Coordinators, 2 Medical Assistants, 3 Data Managers, and 3 Regulatory Specialist. Typically there are 25-35 open and accruing trials with 3-5 more pending. The trials cover a variety of cancer diagnoses. Highlands Oncology Group, PA has the privilege of being the only community Phase I Oncology clinical site in the state of Arkansas.

Clinical trials are a treatment option for many people living with cancer. The next few pages may help to explain clinical trials and give you something to think about when deciding whether or not to participate.

 

CA209-592 NSCLC Stage IV LUNG - Non Small Cell Cancer (NSCLC) 06/25/2017 View Here
WO30070 UNTREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA OTHER 06/25/2017 View Here
4010-01-001 Advanced solid Tumors OTHER 06/25/2017 View Here
No prior treatment for metastatic disease. Local recurrence following surgical resection excluded. Initial diagnosis of metastatic disease < 6 weeks prior to randomization. No Coumadin. CNS mets excluded. PANCREATIC 06/25/2017 View Here
CO39262 Melanoma MELANOMA 06/25/2017 View Here
BDX-00146 (INSIGHT) LUNG - Non Small Cell Cancer (NSCLC) 06/25/2017 View Here
Phase 3 randomized, double-blind, placebo-controlled, multicenter study to compare the efficacy and safety of lenalidomide (CC-5013) plus R-CHOP chemotherapy (R2-CHOP) versus placebo plus R-CHOP chemotherapy in subjects with previously untreated activated B-cell type diffuse large B-cell lymphoma LYMPHOMA 06/25/2017 View Here
A Phase 3, randomized, double-blind, 2-arm study of Avelumab (Anti PDL1)/ in combination with SOC chemoradiation (Cisplatin) vs. SOC chemoradiation. HEAD/NECK 06/25/2017 View Here
Daratumumab plus Cyclophosphamide, Bortezomib and Dexamethasone (Dara-CyBorD) in Previously Untreated and Relapsed Subjects with Multiple Myeloma MULTIPLE MYELOMA 06/25/2017 View Here
CBYL719C2301 Breast Cancer – Hormone receptor positive, HER2- negative BREAST 06/25/2017 View Here
Genentech WO29522 Metastatic Triple Negative Breast Cancer- BREAST 06/25/2017 View Here
AZ D6015C00001 (REMFAL 383) Advanced Solid Tumors OTHER 06/25/2017 View Here
RTOG3508/AbbVie M13-813 Glioblastoma- Newly Diagnosed OTHER 06/25/2017 View Here
CLBH589D2222 Previously treated Multiple Myeloma with 1 to 3 relapses MULTIPLE MYELOMA 06/25/2017 View Here
I4D-MC-JTJH SCLC Previously Treated Extensive Stage LUNG - Small Cell Cancer (SCLC) 06/25/2017 View Here
G1T28-02 Extensive-Stage Small Cell Lung Cancer LUNG - Small Cell Cancer (SCLC) 06/25/2017 View Here
CMCS110Z2201 TNBC Metastatic Breast using Mab BREAST 06/25/2017 View Here
“Vaccination of High Risk Breast Cancer Patients” BREAST 06/25/2017 View Here
SWOG S1207 Breast BREAST 06/25/2017 View Here
HALO 109-301 Pancreatic PANCREATIC 06/25/2017 View Here
B9991009 OVARIAN CANCER-REFRACTORY OVARIAN 06/25/2017 View Here
UTX-TGR-304 Lymphocytic Leukemia- Chronic LEUKEMIA - Chronic Lymphocytic 06/25/2017 View Here
GU 115 / I6A-MC-CBBD Metastatic Castration Resistant Prostate Cancer PROSTATE 06/25/2017 View Here
D6015C00001 Advanced Solid Tumor OTHER 06/25/2017 View Here
I4T-MC-JVDC Unresectable or Metastatic Urothelial Carcinoma OTHER 06/25/2017 View Here
CLDK378A2112 NSCLC Metastatic (ALK-Positive) LUNG - Non Small Cell Cancer (NSCLC) 06/25/2017 View Here
103A-301 Melanoma- Post-resection with a High Risk of Occurrence MELANOMA 06/25/2017 View Here
408-C-1401 Melanoma-Unresectable or Metastatic MELANOMA 06/25/2017 View Here
GO29537 NSCLC Stage Iv Non-Squamous LUNG - Non Small Cell Cancer (NSCLC) 06/25/2017 View Here
GO29437 NSCLS Stage IV Squamous LUNG - Non Small Cell Cancer (NSCLC) 06/25/2017 View Here
8400-401 Waldenström’s Macroglobulinemia - Relapsed or Refractory WALDENSTROM MACROGLOBULINEMIA 06/25/2017 View Here
UTX-IB-301 Chronic Lymphocytic Leukemia- Previously Treated LEUKEMIA - Chronic Lymphocytic 06/25/2017 View Here
Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry OTHER 06/25/2017 View Here
ML28897-PRO02 Pathway Activated Solid Tumors OTHER 06/25/2017 View Here
I3Y-MC-JPBK NSCLC IV - KRAS MUTATION LUNG - Non Small Cell Cancer (NSCLC) 06/25/2017 View Here
A041-04 Renal Cell Carcinoma - Advanced RENAL CELL 06/25/2017 View Here
I3Y-MC-JPBJ NSCLC- Stage IV-Phase 1 LUNG - Non Small Cell Cancer (NSCLC) 06/25/2017 View Here

Quick Contact




captcha